These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 6267173)
21. Induction of natural killer cells by herpes-simplex virus type 2 in resistant and sensitive inbred mouse strains. Armerding D; Rossiter H Immunobiology; 1981; 158(4):369-79. PubMed ID: 6263793 [TBL] [Abstract][Full Text] [Related]
22. Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence. Chrisp CE; Sunstrum JC; Averill DR; Levine M; Glorioso JC Lab Invest; 1989 Jun; 60(6):822-30. PubMed ID: 2543866 [TBL] [Abstract][Full Text] [Related]
23. Neurovirulence and latency in inbred mice of two HSV-1 intrastrain variants of divergent pathogenicity. Kümel G; Schröder CH; Kaerner HC Med Microbiol Immunol; 1986; 174(6):313-24. PubMed ID: 3005814 [TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus type 1 (HSV-1) UL56 gene is involved in viral intraperitoneal pathogenicity to immunocompetent mice. Berkowitz C; Moyal M; Rösen-Wolff A; Darai G; Becker Y Arch Virol; 1994; 134(1-2):73-83. PubMed ID: 8279961 [TBL] [Abstract][Full Text] [Related]
25. Effect of immunization on the development of latent ganglionic infection in mice challenged intravaginally with herpes simplex virus types 1 and 2. Asher LV; Walz MA; Notkins AL Am J Obstet Gynecol; 1978 Aug; 131(7):788-91. PubMed ID: 210669 [TBL] [Abstract][Full Text] [Related]
26. HSV-1 retinitis and delayed hypersensitivity in DBA/2 and C57BL/6 mice. Kielty D; Cousins SW; Atherton SS Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):1994-9. PubMed ID: 2824401 [TBL] [Abstract][Full Text] [Related]
27. Experimental infection of inbred mice with herpes simplex virus. V. Investigations with a virus strain non-lethal after peripheral infection. Kümel G; Kirchner H; Zawatzky R; Engler H; Schröder CH; Kaerner HC J Gen Virol; 1982 Dec; 63(2):315-23. PubMed ID: 6185625 [No Abstract] [Full Text] [Related]
28. Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction. Zawatzky R; Hilfenhaus J; Marcucci F; Kirchner H J Gen Virol; 1981 Mar; 53(Pt 1):31-8. PubMed ID: 6168735 [TBL] [Abstract][Full Text] [Related]
29. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. Bukowski JF; Welsh RM J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892 [TBL] [Abstract][Full Text] [Related]
30. Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice. Abghari SZ; Stulting RD Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):239-43. PubMed ID: 2828265 [TBL] [Abstract][Full Text] [Related]
31. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Ellison AR; Yang L; Voytek C; Margolis TP Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323 [TBL] [Abstract][Full Text] [Related]
32. Mutations in the UL53 gene of HSV-1 abolish virus neurovirulence to mice by the intracerebral route of infection. Moyal M; Berkowitz C; Rösen-Wolff A; Darai G; Becker Y Virus Res; 1992 Nov; 26(2):99-112. PubMed ID: 1335675 [TBL] [Abstract][Full Text] [Related]
33. [Latent infection of cervical ganglia of the mouse by different strains of herpes simplex virus (HSV)]. Meguenni S; Bandoui D; Lahlou Y; el Kolli J; Bouguermouh A Arch Inst Pasteur Alger; 1988; 56():243-52. PubMed ID: 2855821 [No Abstract] [Full Text] [Related]
34. [Mixed latent infection induced by pathogenic herpes simplex virus (HSV) in cervical ganglia of the BALB/c mouse]. Meguenni S; Bandoui D; Lahlou Y; el Kolli J; Bouguermouh A Arch Inst Pasteur Alger; 1988; 56():233-42. PubMed ID: 2855820 [No Abstract] [Full Text] [Related]
35. The effects of stress on memory cytotoxic T lymphocyte-mediated protection against herpes simplex virus infection at mucosal sites. Wonnacott KM; Bonneau RH Brain Behav Immun; 2002 Apr; 16(2):104-17. PubMed ID: 11908921 [TBL] [Abstract][Full Text] [Related]
36. Infections of susceptible and resistant mouse strains with herpes simplex virus type 1 and 2. Caspary L; Schindling B; Dundarov S; Falke D Arch Virol; 1980; 65(3-4):219-27. PubMed ID: 6251783 [TBL] [Abstract][Full Text] [Related]
37. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells. Schrier RD; Ishioka GY; Pizer LI; Moorhead JW J Immunol; 1985 May; 134(5):2889-93. PubMed ID: 2580006 [TBL] [Abstract][Full Text] [Related]
38. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes. Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457 [TBL] [Abstract][Full Text] [Related]
39. Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein C. Johnson DC; McDermott MR; Chrisp C; Glorioso JC J Virol; 1986 Apr; 58(1):36-42. PubMed ID: 3005656 [TBL] [Abstract][Full Text] [Related]
40. Protection against establishment of latent infections in mice immunized with a non-pathogenic herpes simplex virus mutant and reinfected with the pathogenic parental strain. Klein RJ; Kaley LA; Friedman-Kien AE Vaccine; 1984 Sep; 2(3):219-23. PubMed ID: 6099650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]